EP Patent

EP2243468A1 — Orally Disintegrating Dimebolin Compositions

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2010-10-27 · 16y expired

What this patent protects

According to the present invention an orally disintegrating composition comprising dimebolin or a pharmaceutically acceptable salt thereof together with one or more pharmaceutically acceptable excipients is provided.

USPTO Abstract

According to the present invention an orally disintegrating composition comprising dimebolin or a pharmaceutically acceptable salt thereof together with one or more pharmaceutically acceptable excipients is provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP2243468A1
Jurisdiction
EP
Classification
—
Expires
2010-10-27
Drug substance claim
No
Drug product claim
No
Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.